Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 4

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(4)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06359587Not ApplicableRecruiting

Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia

Role: collaborator

NCT07055542Not ApplicableRecruiting

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Role: collaborator

NCT04322136Not ApplicableCompleted

AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

Role: collaborator

NCT05204550Phase 2Completed

Intranasal Heparin Treatment to Reduce Transmission Among Household Contacts of COVID 19 Positive Adults and Children

Role: collaborator

NCT05366153Recruiting

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer

Role: collaborator

NCT02223624Not ApplicableCompleted

Effect of an Eccentric Exercise Program on Quality of Life and Function in People With Chronic Heart Failure.

Role: collaborator

NCT01776567Phase 4Unknown

Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms

Role: lead

All 7 trials loaded